John Kauffman, MD | |
3700 S Main St, Blacksburg, VA 24060-7017 | |
(540) 951-1111 | |
(866) 700-3047 |
Full Name | John Kauffman |
---|---|
Gender | Male |
Speciality | Hospitalist |
Location | 3700 S Main St, Blacksburg, Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427279892 | NPI | - | NPPES |
1427279892 | Medicaid | VA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 0102201953 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
John Kauffman, MD 3700 S Main St, Blacksburg, VA 24060-7017 Ph: (540) 951-1111 | John Kauffman, MD 3700 S Main St, Blacksburg, VA 24060-7017 Ph: (540) 951-1111 |
News Archive
Top-line data from the 270-patient global Phase 2/3 COVID-19 study expected Q1/2021. Top-line data from the 40-patient U.S. Phase 2 study of opaganib in severe COVID-19 expected in the coming days; this non-powered study was designed to evaluate safety and potential identification of preliminary efficacy signals in support of the global Phase 2/3 study of opaganib.
Patients with excited delirium who are combative, aggressive or agitated before being transported to the hospital or in an emergency department setting require immediate treatment for their safety and others.
In a new study, Danilo Perrotti and colleagues from Ohio State University, Columbus, show that treatment with a drug known as FTY720 prevents disease in a mouse model of many leukemias caused by the cancer protein BCR-ABL (nearly all cases of blast crisis chronic myeloid leukemia [CML-BC] and some cases of acute lymphocytic leukemia [ALL]).
Treatment with the targeted therapy drug crizotinib effectively halts the growth of lung tumors driven by rearrangements of the ROS1 gene. In an article receiving Online First publication in the New England Journal of Medicine to coincide with a presentation at the European Society for Medical Oncology meeting, an international research team reports that crizotinib treatment led to significant tumor shrinkage in 36 of 50 study participants and suppressed tumor growth in another 9.
Democrats and Republicans alike are girding for the unveiling of the 2013 budget plan by House Budget Committee Chairman Paul Ryan, R- Wis., and its provisions to overhaul Medicare.
› Verified 3 days ago
Joseph Cacioppo, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3700 S Main St, Blacksburg, VA 24060 Phone: 540-951-1111 | |
Dr. William Sean Cox, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3700 S Main St, Blacksburg, VA 24060 Phone: 540-951-3020 Fax: 866-700-3047 | |
Joshua Terrell Carpenter, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3700 S Main St, Blacksburg, VA 24060 Phone: 540-953-5445 |